Genaera Corporation — Plymouth Meeting, Pennsylvania

Genaera Corporation is a clinical research site located in Plymouth Meeting, Pennsylvania, United States 19462.

Crixeo Clinical Trials Trust Score: 8/100 (FAILING). This profile has not yet been claimed by the site owner.

Genaera Corporation has participated in 3 clinical trials.

Therapeutic areas: "Wet" Age-Related Macular Degeneration, Macular Degeneration.

Sponsors: Genaera Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Plymouth Meeting

Browse all research sites in Pennsylvania · View every site in Plymouth Meeting

• Dermatology Associates of Plymouth Meeting
• Keystone Clinical Studies
• Shafer Vision Institute
• Flourish Research
• Flourish Research ? Philadelphia
• Sage Investigational Site
• Galderma Investigational Site 8802
• Clinical Site
• Dermatology Associates of Plymouth Meeting- P.C.
• Institute of Addiction Medicine
• Pfizer Investigational Site
• Investigative Site 021

Sponsor Feasibility Report

Trust Score: 8/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Genaera Corporation?

Genaera Corporation has a Crixeo Trust Score of 8/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Genaera Corporation conducted?

Genaera Corporation has 3 clinical trials on record. Their work covers "Wet" Age-Related Macular Degeneration, Macular Degeneration.

Is Genaera Corporation accredited by Crixeo Clinical Trials?

Genaera Corporation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Genaera Corporation?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.